Literature DB >> 25934184

Clinical evolution, neuroimaging, and volumetric analysis of a patient with a CSF1R mutation who presented with progressive nonfluent aphasia.

Dokyung Lee1, Ji Young Yun2, Jee Hyang Jeong2, Kunihiro Yoshida3, Sonomi Nagasaki4, Tae-Beom Ahn5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25934184     DOI: 10.1016/j.parkreldis.2015.04.010

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  5 in total

1.  Three novel mutations in Chinese patients with CSF1R-related leukoencephalopathy.

Authors:  Min Chu; Dong-Xin Wang; Yue Cui; Yu Kong; Li Liu; Ke-Xin Xie; Tian-Xinyu Xia; Jing Zhang; Ran Gao; Ai-Hong Zhou; Chao-Dong Wang; Li-Yong Wu
Journal:  Ann Transl Med       Date:  2021-07

Review 2.  Redefining the phenotype of ALSP and AARS2 mutation-related leukodystrophy.

Authors:  Rahul Lakshmanan; Matthew E Adams; David S Lynch; Justin A Kinsella; Rahul Phadke; Jonathan M Schott; Elaine Murphy; Jonathan D Rohrer; Jeremy Chataway; Henry Houlden; Nick C Fox; Indran Davagnanam
Journal:  Neurol Genet       Date:  2017-02-15

3.  CSF1R Mutation p.G589R and the Distribution Pattern of Brain Calcification.

Authors:  Kensuke Daida; Kenya Nishioka; Yuanzhe Li; Sho Nakajima; Ryota Tanaka; Nobutaka Hattori
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

4.  An Autopsy Proven Case of CSF1R-mutant Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) with Premature Ovarian Failure.

Authors:  Seong-Ik Kim; Beomseok Jeon; Jeongmo Bae; Jae Kyung Won; Han-Joon Kim; Jeemin Yim; Yun Joong Kim; Sung-Hye Park
Journal:  Exp Neurobiol       Date:  2019-02-28       Impact factor: 3.261

5.  Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation.

Authors:  T Konno; K Yoshida; T Mizuno; T Kawarai; M Tada; H Nozaki; S-I Ikeda; M Nishizawa; O Onodera; Z K Wszolek; T Ikeuchi
Journal:  Eur J Neurol       Date:  2016-09-29       Impact factor: 6.089

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.